Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Change in Receivables (2019 - 2025)

Evolus (EOLS) has disclosed Change in Receivables for 7 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 25.15% year-over-year to $4.8 million, compared with a TTM value of $11.5 million through Dec 2025, down 41.29%, and an annual FY2025 reading of $11.5 million, down 41.29% over the prior year.
  • Change in Receivables was $4.8 million for Q4 2025 at Evolus, down from $4.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $9.5 million in Q2 2024 and bottomed at -$1.3 million in Q1 2021.
  • Average Change in Receivables over 5 years is $2.8 million, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Change in Receivables tumbled 153.32% in 2021, then surged 2435.76% in 2024.
  • Year by year, Change in Receivables stood at $1.5 million in 2021, then grew by 21.09% to $1.8 million in 2022, then crashed by 91.44% to $151000.0 in 2023, then soared by 2435.76% to $3.8 million in 2024, then grew by 25.15% to $4.8 million in 2025.
  • Business Quant data shows Change in Receivables for EOLS at $4.8 million in Q4 2025, $4.9 million in Q3 2025, and $958000.0 in Q2 2025.